Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus
- 1 October 2001
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (10), 796-802
- https://doi.org/10.1038/sj.cgt.7700367
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 30 references indexed in Scilit:
- Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus—mediated complementary DNAJournal of Neurosurgery, 2001
- Cloning, Expression, andin VitroActivity of Human EndostatinBiochemical and Biophysical Research Communications, 1999
- Gene therapy strategies for tumor antiangiogenesisJNCI Journal of the National Cancer Institute, 1998
- A Simple and Reliable Method for Screening Retroviral Producer Clones Without Selectable MarkersHuman Gene Therapy, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenovirusesNature Genetics, 1993
- Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in VivoScience, 1991
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989